Many people will blame why not buy ucrest at 26c later... If you are not in yet..
Vaccine is hot topic today and demand is huge...
Ucrest unlike other property firm or con counters signing MOU for vaccine distribution.. Ucrest is all time in healthcare business and this is their area of expertise...
Furthermore MOU signing with Russia sourvelian fund but not kucing kurap company...
The deal will definitely go through because ucrest is only 3rd party for project coordination..
Can only say timing bit late. lol.. If this news is released back to when healthcare theme is in play, it will be RM1+ fast and easy... Where is the east wind??
UCrest: Inks deal with Russian sovereign wealth fund to mass-produce Sputnik V.
UCrest signed a strategic deal with Russian Direct Investment Fund (RDIF) to manage and produce 200m doses and up to 2bn doses of Sputnik V, the Covid-19 vaccines in the first two years with the offtake commitment of take or pay basis.
UCrest is partnering, arranging and managing the contract manufacturers in Asia to produce no less than 100m doses and up to 1bn doses in the first year. (Business Times)
so the mou is for 2 yrs...200 m to 2 bil dose.
1st yr 100m to 1bil does.
.....think they will identify n qualify the manufacturer soon. coz 1 yr past very fast.
"UCrest has been actively involved with RDIF in identifying and qualifying contract manufacturers in Asia and will be transferring the technologies from RDIF and Gamaleya for mass production," the group said.
meaning..b4 the mou is signed they r oledi involved with identifying and qualifying. and WILL be transferring technologies.
Eg Kah Yee, Chairman and CEO of UCrest, said: “Since the outbreak, we have been actively involved in various health projects to fight the virus, including tracking Covid-19 symptoms and intelligently assessing and treating the disease for every user of iMedicTM, including patient monitoring and management with ventilators and oximeters in hospitals or at home with the digital health platform. “
Under the terms of the agreement, UCrest ̵ Sputnik V Primarily active in products and services for wireless and digital networks – is responsible for identifying, organizing and monitoring contract manufacturers of Sputnik V in Asia at various suitable production sites.
UCrest has been actively involved with RDIF in the identification and qualification of contract manufacturers in Asia and will transfer RDIF and Gamaleya’s technologies for mass production.
The contract manufacturers’ management includes sourcing materials, coordinating work between manufacturers, obtaining the necessary permits to manufacture and delivering the required cans.
RDIF, meanwhile, will be responsible for the technology transfer and full purchase of the product.
RDIF buys from UCrest and is required to take or pay for the vaccines it produces,” the file said.
UCrest said the agreement could include production between 100 million and one billion cans per year. It depends on the “well-established activities in China, Taiwan and Singapore” and Malaysia.
Ucrest to give anyone to be vaccinated with Sputnik V free access to the iMedic platform to track symptoms, allergies or side effects, as well as disease management for as long as necessary, and this data will in the future be very useful to improve the effectiveness and also the treatment of Covid-19 patients.
It has been reported that RDIF has made contract manufacturing agreements for Sputnik V in India, South Korea and Iran to allow Russia to catch up with global demand for the vaccine.
RDIF has also signed similar deals in Brazil and Serbia that will primarily serve domestic demand. Other that Italy would become the first EU country to manufacture the Russian vaccine in July.
Yesterday,s trading seems that price blocked at 0.265 and collection at 0.260. So, those contra players and weak holders would be washed out from the game.
Vaccine is not life time and effective only for certain period, so this is an ongoing business. That is what i say if the vaccine go smoothly and so is the price.
Hold and see end month Q result. Buy when market not coverage this counter. From one person乐学covering until now, i only see price keep going up. Always sell on good news, drop back, then climb up to next level hgh
This MOU is quite clear and convincing comparing to other vague MOU by other dubious company based on
Time frame and Qty:
1st yr 100m to 1b 2nd yr 100m to 1b 3rd yr :The production plan of the third year will be adjusted according to market dynamics at that time.
Clear Responsibilties of both parties:
UCrest
shall be responsible for identifying, arranging and supervising contract manufacturing in Asia of Covid-19 vaccine at various suitable manufacturing facilities;
RDIF
RDIF shall be responsible for technology transfer and purchase/offtake of 100% of such production; and
RDIF shall purchase from UCrest and is committed to take or pay of the vaccines produced
Condition for follow up binding contractual agreement Upon appointment of Manufacturer by UCREST and transfer of technology by RDIF.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
156563
1,475 posts
Posted by 156563 > 2021-04-12 09:57 | Report Abuse
今天可能会上升限制咯